-
-
-
-
-
-
-
TD Cowen Starts C4 Therapeutics (CCCC) at Buy
-
-
-
-
-
-
-
Guggenheim Starts C4 Therapeutics (CCCC) at Buy
-
-
-
-
-
-
-
C4 Therapeutics Inc. (CCCC) Appoints Paige Mahaney as Chief Scientific Officer, Stewart Fisher Retires
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC)
-
-
446,787 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

